Citigroup’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $704K | Sell |
108,371
-56,305
| -34% | -$366K | ﹤0.01% | 2719 |
|
|
2025
Q1 | $1.31M | Buy |
164,676
+8,442
| +5% | +$66.9K | ﹤0.01% | 2382 |
|
|
2024
Q4 | $1.98M | Buy |
156,234
+108,164
| +225% | +$1.37M | ﹤0.01% | 2141 |
|
|
2024
Q3 | $670K | Buy |
48,070
+14,065
| +41% | +$196K | ﹤0.01% | 2816 |
|
|
2024
Q2 | $469K | Sell |
34,005
-137,045
| -80% | -$1.89M | ﹤0.01% | 2733 |
|
|
2024
Q1 | $2.83M | Buy |
171,050
+71,125
| +71% | +$1.17M | ﹤0.01% | 1586 |
|
|
2023
Q4 | $1.46M | Sell |
99,925
-740
| -0.7% | -$10.8K | ﹤0.01% | 1881 |
|
|
2023
Q3 | $1.24M | Buy |
100,665
+4,234
| +4% | +$52K | ﹤0.01% | 1763 |
|
|
2023
Q2 | $1.15M | Sell |
96,431
-56,567
| -37% | -$675K | ﹤0.01% | 2141 |
|
|
2023
Q1 | $2.05M | Buy |
152,998
+62,985
| +70% | +$842K | ﹤0.01% | 1524 |
|
|
2022
Q4 | $1.94M | Sell |
90,013
-41,733
| -32% | -$898K | ﹤0.01% | 1544 |
|
|
2022
Q3 | $2.64M | Buy |
131,746
+128,981
| +4,665% | +$2.58M | ﹤0.01% | 1436 |
|
|
2022
Q2 | $49K | Buy |
2,765
+562
| +26% | +$9.96K | ﹤0.01% | 3868 |
|
|
2022
Q1 | $22K | Sell |
2,203
-2,479
| -53% | -$24.8K | ﹤0.01% | 4360 |
|
|
2021
Q4 | $79K | Buy |
4,682
+3,403
| +266% | +$57.4K | ﹤0.01% | 4073 |
|
|
2021
Q3 | $30K | Buy |
+1,279
| New | +$30K | ﹤0.01% | 4275 |
|